UTI Mutual Fund

UTI Mutual Fund bought 5,783,600 shares of Meesho Limited for ₹107.57 Cr at ₹186.00 per share in a block deal. This transaction was part of a larger block deal where 10.48 crore shares, representing 2.27% of Meesho's equity, changed hands for approximately ₹1,949 crore.

UTI Mutual Fund increased its stake in Dr. Lal Path Labs to 2.64% from 2.52%, increasing its shareholding from 4,223,290 to 4,430,364 shares. The value of the additional 207,074 shares was approximately ₹35.18 Cr based on the share price of ₹1699.00.

UTI Mutual Fund increased its stake in Info Edge (India) Limited from 2.33% to 2.56%, acquiring 1,538,173 shares. The value of these additional shares is approximately ₹179.35 crore, based on a share price of ₹1165.50.

UTI Mutual Fund decreased its stake in Orchid Pharma Limited from 3.60% to 3.46% by selling 68,325 shares.

UTI Mutual Fund is no longer listed among CEAT Limited's disclosed shareholders, indicating either a complete exit or a reduction of its stake to below the 1 percent reporting requirement.

UTI Mutual Fund decreased its stake in United Foodbrands from 8.55% to 7.66% by selling 3,45,375 shares. The shares were valued at ₹24.24 crore at a price of ₹701.90 apiece.

UTI Mutual Fund decreased its stake in Caplin Point Laboratories from 1.85% to 1.81%, selling 30,340 shares. This transaction is valued at approximately ₹7.58 Cr based on the share price of ₹2499.70.

UTI Mutual Fund, which previously held 1.0 percent of Kiri Industries Limited, is no longer listed among the company's disclosed shareholders, indicating either a complete exit or a reduction in its stake to below the 1 percent reporting threshold.

UTI Mutual Fund decreased its stake in Astral Limited from 2.06% to 1.91%, selling 398,597 shares. With Astral's share price at ₹1532.80, the transaction value is approximately ₹61.09 crore.